Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(7 sites)

United States

University of Alabama, Birmingham, Alabama

Flourish Research, Boca Raton, Florida

Massachusetts General Hospital, Boston, Massachusetts

University of Michigan, Ann Arbour, Michigan

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

UT Southwestern Medical Center, Dallas, Texas

The Medical College of Wisconsin, Milwaukee, Wisconsin